by John Conrad | Jun 4, 2024 | NewsBrief
In a groundbreaking development, scientists at the University of Chicago have created a prototype for “living bioelectronics”—a remarkable combination of living cells, gel, and electronics that can seamlessly integrate with living tissue. This innovative...
by John Conrad | Jun 3, 2024 | NewsBrief
In a major deal announced today, medical technology leader BD (Becton, Dickinson and Company) has agreed to acquire the Critical Care product group from Edwards Lifesciences for $4.2 billion in cash. The acquisition significantly expands BD’s portfolio of...
by John Conrad | May 31, 2024 | NewsBrief
A groundbreaking technology developed by researchers at Southern Illinois University Carbondale could help solve two major global issues at once – food insecurity and plastic waste accumulation. Their system, called μBites, can convert biomass and plastic waste...
by John Conrad | May 30, 2024 | NewsBrief
Scientists have made a breakthrough in the fight against harmful, antibiotic-resistant gram-negative bacteria. A study published in the journal Nature details a newly developed antibiotic compound called lolamicin that can kill pathogenic gram-negative bacteria, even...
by John Conrad | May 29, 2024 | NewsBrief
Early drug development requires critical decisions under severe time and cost pressure. Data comes from multiple parallel activities and identifying possible key risks can be a challenge for companies with limited resources, a position many small biotechs find...
by John Conrad | May 28, 2024 | NewsBrief
Eli Lilly and Company just announced a massive $9 billion investment in a new manufacturing site in Lebanon, Indiana. This represents an increase from the initially planned $3.7 billion investment at the same site, more than doubling Lilly’s commitment. The...
